Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
+17.3M
-
Total reported value, excl. options
-
$298M
-
Value change
-
+$298M
-
Number of buys
-
41
-
Price
-
$17.35
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2018
41 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q2 2018.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
.
Largest 10 shareholders include Hillhouse Capital Management, Ltd. (5.74M shares), BAKER BROS. ADVISORS LP (3M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.23M shares), BOXER CAPITAL, LLC (1.17M shares), Sofinnova Ventures Inc (923K shares), FMR LLC (903K shares), Cormorant Asset Management, LP (831K shares), AMERIPRISE FINANCIAL INC (722K shares), VHCP Management II, LLC (639K shares), and EVENTIDE ASSET MANAGEMENT, LLC (296K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.